Ameritas Investment Partners’s Aldeyra Therapeutics ALDX Stock Holding History

Ameritas Investment Partners’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.5K	Hold	3,846	–	–	﹤0.01%	2946
2025 Q4	$19.9K	Hold	3,846	–	–	﹤0.01%	2645
2025 Q3	$20.1K	Hold	3,846	–	–	﹤0.01%	2661
2025 Q2	$14.7K	Hold	3,846	–	–	﹤0.01%	2809
2025 Q1	$22.1K	Hold	3,846	–	–	﹤0.01%	2507
2024 Q4	$19.2K	Hold	3,846	–	–	﹤0.01%	2650
2024 Q3	$20.7K	Hold	3,846	–	–	﹤0.01%	2639
2024 Q2	$12.7K	Hold	3,846	–	–	﹤0.01%	2831
2024 Q1	$12.6K	Hold	3,846	–	–	﹤0.01%	2753
2023 Q4	$13.5K	Hold	3,846	–	–	﹤0.01%	2743
2023 Q3	$25.7K	Hold	3,846	–	–	﹤0.01%	2426
2023 Q2	$32.3K	Buy	+3,846	New	+$37.9K	﹤0.01%	2296
2022 Q2	–	Sell	-3,805	Closed	-$17K	–	3060
2022 Q1	$17K	Hold	3,805	–	–	﹤0.01%	2614
2021 Q4	$15K	Hold	3,805	–	–	﹤0.01%	2755
2021 Q3	$33K	Hold	3,805	–	–	﹤0.01%	2406
2021 Q2	$43K	Buy	+3,805	New	+$45.8K	﹤0.01%	2283
2020 Q2	–	Sell	-1,388	Closed	-$3K	–	3064
2020 Q1	$3K	Hold	1,388	–	–	﹤0.01%	2900
2019 Q4	$8K	Hold	1,388	–	–	﹤0.01%	2794
2019 Q3	$7K	Hold	1,388	–	–	﹤0.01%	2838
2019 Q2	$8K	Hold	1,388	–	–	﹤0.01%	2853
2019 Q1	$13K	Hold	1,388	–	–	﹤0.01%	2584
2018 Q4	$12K	Hold	1,388	–	–	﹤0.01%	2582
2018 Q3	$19K	Hold	1,388	–	–	﹤0.01%	2528
2018 Q2	$11K	Buy	+1,388	New	+$11.1K	﹤0.01%	2802

Other funds holding ALDX

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameritas Investment Partners's ALDX Position: Q1 2026 in Review

Ameritas Investment Partners held its Aldeyra Therapeutics (ALDX) position steady in Q1 2026 at 3,846 shares worth $6.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2946.

Ameritas Investment Partners first reported a position in ALDX in Q2 2018 and has held it in 24 quarters since. The position peaked at $43K in Q2 2021. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

Ameritas Investment Partners held 3,846 shares of Aldeyra Therapeutics worth $6.5K as of Q1 2026.
Ameritas Investment Partners left its Aldeyra Therapeutics share count unchanged in Q1 2026.
Aldeyra Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2946 holding.
Ameritas Investment Partners first reported a position in Aldeyra Therapeutics in Q2 2018 and has held it in 24 quarters since.
Ameritas Investment Partners's Aldeyra Therapeutics position peaked at $43K in Q2 2021.
126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.